You are here: Home: BCU Surgeons 2005 Vol 4 Issue 1: Michael Baum, MD, ChM: Select publications
     
 

Select publications

ATAC Trialists’ Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 2005;365(9453):60-2. Abstract

Coombes RC et al; Intergroup Exemestane Study. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350(11):1081-92. Abstract

Goss PE et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349(19):1793-802. Abstract

Howell A, on behalf of the ATAC Trialists’ Group. “Arimidex,” Tamoxifen Alone or in Combination (ATAC) trial: Completed treatment analysis. Presentation. San Antonio Breast Cancer Symposium 2004;Abstract 1.

 

  
   
     

 
Table of Contents
 
Editor’s Note:
Four very cool dudes
 
Michael Baum, MD, ChM
- Select publications
 
Norman Wolmark, MD
- Select publications
 
Gabriel N Hortobagyi, MD
- Select publications
 
Jay R Harris, MD
- Select publications
 
Faculty Disclosures
CME Information
Editor's office